RegentAtlantic Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.41M | Buy |
42,168
+18,436
| +78% | +$2.02M | 0.13% | 113 |
|
|
2022
Q2 | $2.49M | Sell |
23,732
-2,867
| -11% | -$340K | 0.08% | 178 |
|
|
2022
Q1 | $3.4M | Sell |
26,599
-5,478
| -17% | -$660K | 0.1% | 156 |
|
|
2021
Q4 | $3.96M | Sell |
32,077
-288
| -0.9% | -$37.7K | 0.11% | 147 |
|
|
2021
Q3 | $4.6M | Sell |
32,365
-1,454
| -4% | -$214K | 0.14% | 123 |
|
|
2021
Q2 | $5.28M | Sell |
33,819
-272
| -0.8% | -$44.1K | 0.16% | 110 |
|
|
2021
Q1 | $5.3M | Sell |
34,091
-1,434
| -4% | -$222K | 0.18% | 99 |
|
|
2020
Q4 | $5.32M | Sell |
35,525
-36,631
| -51% | -$5.17M | 0.21% | 87 |
|
|
2020
Q3 | $9.54M | Buy |
72,156
+34,300
| +91% | +$4.48M | 0.43% | 45 |
|
|
2020
Q2 | $4.39M | Sell |
37,856
-93
| -0.2% | -$10.7K | 0.24% | 89 |
|
|
2020
Q1 | $3.72M | Sell |
37,949
-486
| -1% | -$63.7K | 0.29% | 81 |
|
|
2019
Q4 | $5.59M | Sell |
38,435
-3,670
| -9% | -$507K | 0.34% | 77 |
|
|
2019
Q3 | $5.61M | Sell |
42,105
-5,676
| -12% | -$733K | 0.37% | 73 |
|
|
2019
Q2 | $5.46M | Sell |
47,781
-6,817
| -12% | -$798K | 0.37% | 73 |
|
|
2019
Q1 | $6.77M | Buy |
54,598
+2,133
| +4% | +$242K | 0.47% | 57 |
|
|
2018
Q4 | $5.28M | Sell |
52,465
-890
| -2% | -$100K | 0.45% | 70 |
|
|
2018
Q3 | $6.81M | Buy |
53,355
+6,297
| +13% | +$749K | 0.52% | 54 |
|
|
2018
Q2 | $5.09M | Buy |
47,058
+5,095
| +12% | +$555K | 0.44% | 63 |
|
|
2018
Q1 | $4.44M | Buy |
41,963
+29,628
| +240% | +$3.44M | 0.37% | 78 |
|
|
2017
Q4 | $1.45M | Buy |
12,335
+69
| +0.6% | +$7.8K | 0.12% | 184 |
|
|
2017
Q3 | $1.39M | Sell |
12,266
-119
| -1% | -$13.7K | 0.12% | 181 |
|
|
2017
Q2 | $1.54M | Sell |
12,385
-36
| -0.3% | -$4.27K | 0.14% | 157 |
|
|
2017
Q1 | $1.47M | Sell |
12,421
-84
| -0.7% | -$9.52K | 0.14% | 162 |
|
|
2016
Q4 | $1.25M | Sell |
12,505
-196
| -2% | -$21K | 0.12% | 174 |
|
|
2016
Q3 | $1.6M | Sell |
12,701
-106
| -0.8% | -$13.1K | 0.17% | 141 |
|
|
2016
Q2 | $1.5M | Sell |
12,807
-232
| -2% | -$26.3K | 0.14% | 145 |
|
|
2016
Q1 | $1.35M | Sell |
13,039
-653
| -5% | -$63.2K | 0.15% | 142 |
|
|
2015
Q4 | $1.36M | Sell |
13,692
-1,222
| -8% | -$120K | 0.15% | 157 |
|
|
2015
Q3 | $1.36M | Sell |
14,914
-55
| -0.4% | -$5.51K | 0.13% | 158 |
|
|
2015
Q2 | $1.59M | Sell |
14,969
-215
| -1% | -$23.8K | 0.14% | 151 |
|
|
2015
Q1 | $1.73M | Sell |
15,184
-577
| -4% | -$65.8K | 0.15% | 140 |
|
|
2014
Q4 | $1.74M | Sell |
15,761
-492
| -3% | -$51.9K | 0.15% | 141 |
|
|
2014
Q3 | $1.59M | Sell |
16,253
-148
| -0.9% | -$14.6K | 0.15% | 141 |
|
|
2014
Q2 | $1.65M | Sell |
16,401
-640
| -4% | -$62.4K | 0.15% | 135 |
|
|
2014
Q1 | $1.56M | Sell |
17,041
-154
| -0.9% | -$14.2K | 0.15% | 136 |
|
|
2013
Q4 | $1.56M | Sell |
17,195
-51
| -0.3% | -$4.41K | 0.15% | 139 |
|
|
2013
Q3 | $1.38M | Buy |
17,246
+678
| +4% | +$53.4K | 0.15% | 138 |
|
|
2013
Q2 | $1.21M | Buy |
+16,568
| New | +$1.24M | 0.14% | 138 |
|
Other funds holding ZBH
RegentAtlantic Capital's ZBH Position: Q3 2022 in Review
RegentAtlantic Capital increased its Zimmer Biomet (ZBH) stake by 78% in Q3 2022, buying an estimated $2.02M and bringing the position to 42,168 shares worth $4.41M. The position accounts for 0.13% of the portfolio, ranked #113.
RegentAtlantic Capital first reported a position in ZBH in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.54M in Q3 2020. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.
- RegentAtlantic Capital held 42,168 shares of Zimmer Biomet worth $4.41M as of Q3 2022.
- RegentAtlantic Capital bought 18,436 Zimmer Biomet shares in Q3 2022, an estimated $2.02M.
- Zimmer Biomet made up 0.13% of RegentAtlantic Capital's portfolio in Q3 2022, its #113 holding.
- RegentAtlantic Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Zimmer Biomet position peaked at $9.54M in Q3 2020.
- 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.